| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4a95c7328e9c63a07ce2de92c34d8f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-4633 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-4625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-46 |
| filingDate |
2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d53e9c60e42962ce187ad2e1c6cc7424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c50f75115317f440ed24ea64ba0fa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7f420ac5403f0252e1e7dc88a9e828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfd6076bec76d46b529aa6dde843ce80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c27b9a025b3a2ab3ad43e6aa0721a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c7027dc47b488a6b07275bd9ea99da9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75f52854ba1056fbc05de5da76e12697 |
| publicationDate |
2002-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1224486-A1 |
| titleOfInvention |
Use of double-quantum 1h-nmr spectroscopy for the identification of ligands interacting with target biomolecules |
| abstract |
The present invention provides a rapid and efficient screening procedure for identifying and providing chemical compounds that interact with target biomolecules, for instance a therapeutic target biomolecule such as a protein, wherein the said procedure comprises generating two dimensional proton (refocused or not) double-quantum or double-quantum relaxation weighted double quantum-spectra of a mixture of compounds with and without the target biomolecule, so as to detect any differences between the spectra that identify the presence of one or more chemical compounds that bind to the target biomolecule. |
| priorityDate |
1999-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |